Us Congress 2025-2026 Regular Session

Us Congress House Bill HB3029 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	I
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. R. 3029
5	5	To amend the Research and Development, Competition, and Innovation Act
6	6	to support nucleic acid screening, and for other purposes.
7	7	IN THE HOUSE OF REPRESENTATIVES
8	8	APRIL28, 2025
9	9	Ms. S
10	10	ALINAS(for herself and Mr. MCCORMICK) introduced the following bill;
11	11	which was referred to the Committee on Science, Space, and Technology
12	12	A BILL
13	13	To amend the Research and Development, Competition, and
14	14	Innovation Act to support nucleic acid screening, and
15	15	for other purposes.
16	16	Be it enacted by the Senate and House of Representa-1
17	17	tives of the United States of America in Congress assembled, 2
18	18	SECTION 1. SHORT TITLE. 3
19	19	This Act may be cited ‘‘Nucleic Acid Standards for 4
20	20	Biosecurity Act’’. 5
21	21	SEC. 2. SUPPORTING NUCLEIC ACID SCREENING. 6
22	22	Section 10221 of the Research and Development, 7
23	23	Competition, and Innovation Act (42 U.S.C. 18931; en-8
24	24	acted as part of title II of division B of Public Law 117– 9
25	25	167) is amended— 10
26	26	VerDate Sep 11 2014 09:00 May 06, 2025 Jkt 000000 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H3029.IH H3029
27	27	mprince on LAP1J3WLY3PROD with $$_JOB 2
28	28	•HR 3029 IH
29	29	(1) in subsection (a)(1)— 1
30	30	(A) in subparagraph (C), by striking 2
31	31	‘‘and’’ after the semicolon; 3
32	32	(B) by redesignating subparagraph (D) as 4
33	33	subparagraph (E); and 5
34	34	(C) by inserting after subparagraph (C) 6
35	35	the following new subparagraph: 7
36	36	‘‘(D) best practices, guidelines, and tech-8
37	37	nical standards for risk management associated 9
38	38	with engineering biology and biomanufacturing, 10
39	39	including risks associated with the use of artifi-11
40	40	cial intelligence; and’’; 12
41	41	(2) by redesignating subsections (b) and (c) as 13
42	42	subsections (c) and (d), respectively; and 14
43	43	(3) by inserting after subsection (a) the fol-15
44	44	lowing new subsection: 16
45	45	‘‘(b) N
46	46	UCLEICACIDSYNTHESISSCREENINGTOOLS 17
47	47	ANDSTANDARDS.— 18
48	48	‘‘(1) I
49	49	N GENERAL.—The Director, in consulta-19
50	50	tion with heads of Federal agencies the Director 20
51	51	considers appropriate, shall carry out measurement 21
52	52	research to support the development and improve-22
53	53	ment of best practices and technical standards for 23
54	54	biosecurity measures related to nucleic acid syn-24
55	55	thesis, including the following: 25
56	56	VerDate Sep 11 2014 09:00 May 06, 2025 Jkt 000000 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H3029.IH H3029
57	57	mprince on LAP1J3WLY3PROD with $$_JOB 3
58	58	•HR 3029 IH
59	59	‘‘(A) Testing to improve the accuracy, effi-1
60	60	cacy, and reliability of screening for nucleic acid 2
61	61	synthesis. 3
62	62	‘‘(B) Best practices, including security and 4
63	63	access controls, for operational security and 5
64	64	managing sequence-of-concern databases to 6
65	65	support such screening. 7
66	66	‘‘(C) Technical implementation guidance to 8
67	67	ensure such screening is effective and secure. 9
68	68	‘‘(D) Conformity-assessment best practices 10
69	69	and technical standards. 11
70	70	‘‘(E) Methods to evaluate the impact and 12
71	71	effectiveness of the implementation of subpara-13
72	72	graphs (A) through (D). 14
73	73	‘‘(2) C
74	74	ONSORTIUM.—In carrying out this sub-15
75	75	section, the Director shall convene a consortium of 16
76	76	stakeholders, including industry, institutions of high-17
77	77	er education, nonprofit organizations, and customers 18
78	78	to carry out the following: 19
79	79	‘‘(A) Develop and periodically update con-20
80	80	sensus priorities and best practices, as appro-21
81	81	priate, for synthetic nucleic acid procurement 22
82	82	screening mechanisms. 23
83	83	‘‘(B) Develop roadmaps to inform the ac-24
84	84	tivities carried out under paragraph (1). 25
85	85	VerDate Sep 11 2014 09:00 May 06, 2025 Jkt 000000 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H3029.IH H3029
86	86	mprince on LAP1J3WLY3PROD with $$_JOB 4
87	87	•HR 3029 IH
88	88	‘‘(3) REPORT.—Not later than 18 months after 1
89	89	the first meeting of the consortium under paragraph 2
90	90	(2), the Director shall submit to the Committee on 3
91	91	Commerce, Science, and Transportation of the Sen-4
92	92	ate and the Committee on Science, Space, and Tech-5
93	93	nology of the House of Representatives a report 6
94	94	summarizing the findings of the consortium. 7
95	95	‘‘(4) A
96	96	UTHORIZATION OF APPROPRIATIONS .—Of 8
97	97	the funds authorized to be appropriated for the Na-9
98	98	tional Institute of Standards and Technology pursu-10
99	99	ant to this section for scientific and technical re-11
100	100	search and services laboratory activities, there is au-12
101	101	thorized to be appropriated $5,000,000 for each of 13
102	102	fiscal years 2026 through 2030 to carry out this 14
103	103	subsection.’’. 15
104	104	Æ
105	105	VerDate Sep 11 2014 09:00 May 06, 2025 Jkt 000000 PO 00000 Frm 00004 Fmt 6652 Sfmt 6301 E:\BILLS\H3029.IH H3029
106	106	mprince on LAP1J3WLY3PROD with $$_JOB